Facebook tracking pixelPeripheral Neuropathy - AI-Powered ICD-10 Documentation
G62.9
ICD-10-CM
Peripheral Neuropathy

Find information on peripheral neuropathy diagnosis, including clinical documentation, medical coding, and ICD-10 codes. Learn about symptoms, causes, and treatment options for peripheral neuropathy. Explore resources for healthcare professionals on documenting and coding peripheral neuropathy in medical records, including specific codes like G62.9 and related terms like diabetic neuropathy and polyneuropathy. This resource provides essential information for accurate clinical documentation and medical billing related to peripheral neuropathy.

Also known as

Peripheral Nerve Disorder
Polyneuropathy

Diagnosis Snapshot

Key Facts
  • Definition : Damage to peripheral nerves causing pain, numbness, tingling, and weakness.
  • Clinical Signs : Loss of sensation, muscle weakness, burning pain, numbness in hands and feet.
  • Common Settings : Diabetes, chemotherapy, autoimmune diseases, trauma, infections.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC G62.9 Coding
G60-G64

Polyneuropathies and other disorders of the PNS

Covers various peripheral nerve disorders, including many types of polyneuropathy.

G56-G59

Mononeuropathies of upper limb and mononeuritis multiplex

Includes specific nerve disorders like carpal tunnel and mononeuritis multiplex.

G70-G73

Myoneural diseases and other neuromuscular disorders

Includes conditions affecting the connection between nerves and muscles, sometimes causing neuropathy-like symptoms.

E10-E14

Diabetes mellitus

Diabetic neuropathy is a common type of peripheral neuropathy, coded under the underlying diabetes.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the peripheral neuropathy due to diabetes?

  • Yes

    Code as G63.2 Diabetic polyneuropathy

  • No

    Due to alcohol use?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Peripheral Neuropathy
Diabetic Neuropathy
Carpal Tunnel Syndrome

Documentation Best Practices

Documentation Checklist
  • Peripheral neuropathy diagnosis documented
  • Symptom onset, duration, and character
  • Neurological exam findings (sensory, motor, reflex)
  • Diagnostic tests performed and results (e.g., EMG/NCS)
  • Etiology/cause of neuropathy if known (e.g., diabetic)

Coding and Audit Risks

Common Risks
  • Unspecified Type

    Coding neuropathy without specifying type (e.g., diabetic, toxic) leads to inaccurate DRG assignment and lost revenue.

  • Symptom Coding

    Coding symptoms (e.g., numbness, tingling) instead of the underlying neuropathy diagnosis understates severity and impacts quality metrics.

  • Laterality Neglect

    Failing to document and code laterality (right, left, bilateral) for peripheral neuropathy can lead to claim denials and underpayment.

Mitigation Tips

Best Practices
  • Thorough HPI: Document symptom onset, location, character for ICD-10 code accuracy.
  • NCV/EMG: Ensure medical necessity for G0459, R94.31 per payer guidelines.
  • Medication reconciliation: Document meds linked to PN for proper E/M coding.
  • Comorbidity documentation: Link diabetes, B12 deficiency to PN for risk adjustment.
  • Diabetes management: Optimize A1c control documentation for HCC coding, compliance.

Clinical Decision Support

Checklist
  • 1. Confirm symptoms: numbness, tingling, pain (ICD-10 G62.9)
  • 2. Assess: reflexes, sensation, strength (SNOMED CT 426973000)
  • 3. Rule out: diabetes, B12 deficiency (ICD-10 E11.4, E53.8)
  • 4. Consider EMG/NCS testing (CPT 95903, 95904)
  • 5. Document neuropathy type, severity, etiology

Reimbursement and Quality Metrics

Impact Summary
  • Peripheral Neuropathy reimbursement hinges on accurate ICD-10 (G60-G65) and CPT coding for EMG/NCS studies, medication management, and other therapies, impacting hospital revenue cycle management.
  • Coding errors for Peripheral Neuropathy diagnoses (e.g., misusing G62.9 vs. specific subtype) can lead to claim denials and reduced reimbursement, affecting hospital financial performance.
  • Proper Peripheral Neuropathy documentation and coding influence quality metrics like patient satisfaction, pain management effectiveness, and functional improvement, impacting hospital value-based care.
  • Timely and accurate Peripheral Neuropathy coding facilitates appropriate hospital reporting for epidemiological studies, resource allocation, and healthcare policy decisions.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code G60-G64 per ICD-10
  • Document neuropathy type
  • Specify laterality: R, L, B
  • Confirm diagnosis, rule out other causes
  • Note symptom duration, severity

Documentation Templates

Patient presents with complaints consistent with peripheral neuropathy.  Symptoms include distal paresthesias, described as numbness, tingling, and burning sensations, primarily affecting the bilateral feet and extending up to the ankles.  Onset was gradual over several months.  Patient denies any recent trauma, infection, or known toxic exposures.  Medical history includes type 2 diabetes mellitus, well-controlled with metformin.  Family history is negative for neurological disorders.  Physical examination reveals diminished sensation to light touch and pinprick in a stocking-glove distribution.  Ankle reflexes are hypoactive bilaterally.  Vibratory sensation is reduced in the lower extremities.  Strength is preserved.  Diagnostic considerations include diabetic peripheral neuropathy, idiopathic peripheral neuropathy, and vitamin B12 deficiency.  Initial laboratory workup will include a complete blood count (CBC), comprehensive metabolic panel (CMP), hemoglobin A1c (HbA1c), vitamin B12 levels, and thyroid stimulating hormone (TSH).  Electromyography (EMG) and nerve conduction studies (NCS) are scheduled to assess nerve function.  Differential diagnosis also includes small fiber neuropathy and other causes of peripheral neuropathy.  Treatment plan includes patient education on foot care and the importance of glucose control.  Pharmacological management options for neuropathic pain, such as gabapentin or pregabalin, will be considered based on symptom severity and patient response.  Follow-up appointment scheduled in four weeks to review laboratory results, discuss EMG/NCS findings, and adjust treatment plan as indicated.  Patient advised to return sooner if symptoms worsen.